首頁 > 北榮簡介 > 正副院長及主任秘書介紹 > 高副院長 壽延

:::
正副院長及主任秘書介紹
:::
高副院長 壽延
A- A A+
副院長：  高壽延
服務機構：  臺北榮民總醫院
現職：  臺北榮民總醫院 副院長
 陽明交通大學牙醫學院 兼任教授
地址：  臺北市北投區石牌路二段201號
電話：  886-2-2871-2121
傳真：  886-2-2872-0916
學歷：  國立陽明交通大學學士 1984
 美國哈佛大學牙醫學院 醫學科學博士 1996
 長庚大學醫務管理研究所在職專班 碩士 2002

經歷：

 陽明交通大學專任助教、臺北榮民總兼任住院醫師(1986-1991)
 國科會公費留學(1993-1996)
 陽明交通大學牙醫校友會會長，創辦萌芽會刊(1997-1999)
 中華民國醫院牙科協會秘書長(2000-2002)
 國際牙醫學院院士(2002)
 中華牙醫學會秘書長/理事(2001-2003-2005)
 臺北榮民總醫院口腔醫學部口腔顎面外科主任(2003-2008)
 臺北榮民總醫院口腔醫學部部主任(2008-2016)
 陽明交通大學牙醫學院副院長(2010-2014)
 中華民國口腔顎面外科學會理事長(2011-2013)
 第13屆2018亞洲口腔顎面外科學大會籌委會主委(2015)
 中華民國頭頸愛關懷協會創會首任理事長 (2016)
 亞洲口腔顎面外科學會理事長(2016-2018) 
 亞洲口腔顎面外科學會顧問(2019-)

榮譽獎項： 

 臺北榮民總醫院30週年院慶晚會主持人(1989)
 中華醫學會年度住院醫師組最佳論文獎 (1990)
 臺北榮民總牙科部年度最佳論文獎 (1991)
 臺北榮民總年度臨床工作績優獎 (1992)
 臺北榮民總醫院年度服務工作績優獎個人組第一名 (2000)
 陽明交通大學醫學系學生遴選優良教師 (2004)
 93年度行政院退除役官兵輔導委員會優良醫師 (2004)
 臺北榮民總醫療技術創新獎 (2006)
 口腔醫學部承辦臺北榮民總醫院50週年院慶大會(2009)
 臺北榮民總醫院年度廉政楷模 (2012)
 口腔醫學部獲廉政倫理獎 (2013)
 臺北榮民總醫院年度優良醫師 (2013)
 陽明交通大學行政類傑出校友 (2013)
 衛福部卓越計劃口腔癌團隊主持人 (2014)
 104年行政院模範公務員 (2015)
 口腔癌團隊通過生策會SNQ標章認證 (2016)
 督導通過美國人類研究受試者保護協會認證 (2017)
 第13屆2018亞洲口腔顎面外科學大會主席(2018)
 中華民國口腔顎面外科學會特殊貢獻獎 (2019)
中華民國牙醫師公會全國聯合會特殊貢獻獎金質獎(2020)

專長：

  口腔顎面外科學、口腔腫瘤學、醫務管理
專刊：
  1. 台北榮民總醫院口腔醫學部人工植牙論文選集中英文版
  2. 中華民國口腔顎面外科學會植牙論文選中英文版光碟
  3. 台北榮民總醫院精采100口腔醫學部中英文版
  4. 中華民國口腔顎面外科學會2013年紀念專刊
  5. 口腔頭頸癌跨領域醫療研究與創新-專刊-2015
  6. 第13屆亞洲口腔顎面外科學會議專刊
影音報導：
  1.  2018亞太口腔顎面外科會議-臺北-開幕致詞
  2. 第十三屆亞洲口腔顎面外科學大會-萌芽會訊2018第4季節錄

論文著作

1987 ~ 2021.9共計224篇

  1. Liang KH, Lin YY, Chiang SH, Tsai ET, Lo WL, Wang CL, Wang TY, Sun YC, Kao SY, Wu CH, Hung KF. Recent Progress of Biomarkers in Oral Cancers. J Chin Med Assoc. 2021 Sep 3.
  2. Chang SL, Kuo MJ, Lin YJ, Chen SA, Chen CT, Yang YY, Yang LY, Kao SY, Shulruf B, Lee FY. Virtual reality-based preprocedural education increases preparedness and satisfaction of patients about the catheter ablation of atrial fibrillation. J Chin Med Assoc. 2021 Jul 1;84(7):690-697.
  3. Huang CC, Huang SS, Yang YY, Kao SY. Effects of a simulation-based blended training model on nurses’ treatment decision-related knowledge about oral cancer in Taiwan: a pilot survey. J Educ Eval Health Prof. 2021;18:10.
  4. Chang YA, Wu YY, Lin CT, Kawasumi M, Wu CH, Kao SY, Yang YP, Hsu CC, Hung KF, Sun YC. Animal models of dry eye: Their strengths and limitations for studying human dry eye disease. J Chin Med Assoc. 2021 May 1;84(5):459-464.
  5. Chang SL, Kuo MJ, Lin YJ, Chen SA, Yang YY, Cheng HM, Yang LY, Kao SY, Lee FY. Virtual reality informative aids increase residents' atrial fibrillation ablation procedures-related knowledge and patients' satisfaction. J Chin Med Assoc. 2021 Jan 1;84(1):25-32.
  6. Wu CH、Huang YC、Chiang DH、Yang YY、Yang LY、Kao SY、Chen CH、Lee FY. A quality improvement pilot project of training nurses to use VR educational aids to increase oral cancer patients’pretreatment knowledge and satisfaction. Eur. J. Oncol. Nurs. 2020 Dec 49:101858
  7. Lin SC, Wu HL, Yeh LY, Yang CC, Kao SY , Chang KW. Activation of the miR-371/372/373 miRNA Cluster Enhances Oncogenicity and Drug Resistance in Oral Carcinoma Cells. Int J Mol Sci. 2020 Dec 21（24）：9442
  8. Hung KF, Sun YC, Chen BH, Lo JF, Cheng CM, Chen CY, Wu CH, Kao SY. New COVID-19 saliva-based test: How good is it compared with the current nasopharyngeal or throat swab test? J Chin Med Assoc. 2020 Oct;83(10):891-894.
  9. Cheng HC, Yang CC, Kao SY, Wu TY, Wu CH. Evaluation of factors associated with the risk stratification of survivorship for stage IV squamous cell carcinoma of the oral cavity: A 10-year retrospective study. J Chin Med Assoc. 2020 Mar 2.
  10. The miR-372-ZBTB7A Oncogenic Axis Suppresses TRAIL-R2 Associated Drug Sensitivity in Oral Carcinoma. YehLY, Yang CC, Wu HL, Kao SY, Liu CJ, Chen YF, Lin SC, Chang KW. Front Oncol. 2020 Jan 31;10:47.
  11. Hung KF, Yang T, Kao SY.Cancer stem cell theory: Are we moving past the mist? J Chin Med Assoc. 2019 Nov;82(11):814-818.
  12. Yang MH, Hsu DS, Wang HW, Wang HJ, Lan HY, Yang WH, Huang CH, Kao SY, Tzeng CH, Tai SK, Chang SY, Lee OK, Wu KJ. Author Correction: Bmi1 is essential in Twist1-induced epithelial-mesenchymal transition. Nature Cell Biol. 2019 Apr;21(4):533. 
  13. Shiao TH, Yang YY, Wu CY, Yang LY, Hwang SJ, Huang CC, Liang JF, Kao SY, Lee FY. Creation of nurse-specific integrated inter-professional collaboration and team-efficiency (IIT) scenario/video improves trainees' attitudes and performances. J Chin Med Assoc. 2019 Apr 22: 546-553. 
  14. Shen WC, Lai YC, Li LH, Liao K, Lai HC, Kao SY, Wang J, Chuong CM, Hung SC. Methylation and PTEN activation in dental pulp mesenchymal stem cells promotes osteogenesis and reduces oncogenesis. Nature Communication. 2019 May 20;10(1):2226.
  15.  Hung KF, Liao PC, Chen CK, Chiu YT, Cheng DH, Kawasumi M, Kao SY, Lo JF. ASB6 Promotes the Stemness Properties and Sustains Metastatic Potential of Oral Squamous Cell Carcinoma Cells by Attenuating ER Stress. Int J Biol Sci. 2019 Apr 22;15(5):1080-1090. 
  16. Su CJ, Pan SW, Huang LJ, Yang LY, Yang YY, Hwang SJ, Chuang CL, Chang CC, Huang HC, Kao SY, Lee FY. Trios-OSCE-based simulation course enhances the subcompetency of emergency-stabilization for postgraduate year-1 residents. J Chin Med Assoc. 2019 May;82(5):407-412. 
  17. Shiao TH, Yang YY, Wu CY, Yang LY, Hwang SJ, Huang CC, Liang JF, Kao SY, Lee FY. Creation of nurse-specific integrated inter-professional collaboration and team-efficiency (IIT) scenario/video improves trainees' attitudes and performances. J Chin Med Assoc. 2019 Apr 22:546-553. 
  18. Chien KH, Chang YL, Wang ML, Chuang JH, Yang YC, Tai MC, Wang CY, Liu YY, Li HY, Chen JT, Kao SY, Chen HL, Lo WL. Promoting Induced Pluripotent Stem Cell-driven Biomineralization and Periodontal Regeneration in Rats with Maxillary-Molar Defects using Injectable BMP-6 Hydrogel. Sci Rep.: 2018 Jan 8;8(1):114. 
  19. Chou CH, Tu HF, Kao SY, Chiang CF, Liu CJ, Chang KW, Lin SC. Targeting of miR-31/96/182 to the Numb gene during head and neck oncogenesis. Head Neck.: 2018 Apr;40(4):808-817. 
  20. Chang CW, Chen YS, Tsay YG, Han CL, Chen YJ, Yang CC, Hung KF, Lin CH, Huang TY, Kao SY, Lee TC, Lo JF. ROS-independent ER stress-mediated NRF2 activation promotes warburg effect to maintain stemness-associated properties of cancer-initiating cells. Cell Death Dis.: 2018 Feb 7;9(2):194. 
  21. Lin SC, Lin LH, Yu SY, Kao SY, Chang KW, Cheng HW, Liu CJ.　FAT1 somatic mutations in head and neck carcinoma are associated with tumor progression and survival.　Carcinogenesis.: 2018 Dec 13;39(11):1320-1330. 
  22. Lin LH, Chang KW, Kao SY, Cheng HW, Liu CJ. Increased Plasma Circulating Cell-Free DNA Could Be a Potential Marker for Oral Cancer. Int J Mol Sci. 2018 Oct 24;19(11). pii: E3303 1-13. 
  23. Yang LY, Yang YY, Huang CC, Liang JF, Lee FY, Cheng HM, Huang CC, Kao SY. Simulation-based inter-professional education to improve attitudes towards collaborative practice: a prospective comparative pilot study in a Chinese medical centre. BMJ Open. 2017 Nov 8;7(11). 
  24. Kuo CC, Kao SY, Lui MT, Wu CH. The abscopal effect associated with combined pembrolizumab and radiotherapy in disseminated locaregional/Metastatic disease of advanced head and neck cancer – a case report. 2017  Taiwan J Oral maxillofac Surg 28:263-274. 
  25. Chou CH, Tu HF, Kao SY, Fan Chiang C-Y, Liu CJ, Chang KW*, Lin SC*. Targeting of miR-31/96/182 to the Numb gene during head and neck oncogenesis. Head Neck. 2018 Apr;40(4):808-81. 
  26. Yang LY, Yang YY, Huang CC, Liang JF, Lee FY, Cheng HM, Huang CC, Kao SY. Simulation-based inter-professional education to improve attitudes towards collaborative practice: a prospective comparative pilot study in a Chinese medical centre. BMJ Open. 2017 Nov 8;7(11):e015105 1-11. 
  27. Hung KF, Liu CJ, Chiu PC, Lin JS, Chang KW, Shih WY, Kao SY, Tu HF. MicroRNA-31 upregulation predicts increased risk of progression of oral potentially malignant disorder. Oral Oncology. 2016.53 :42–47. 
  28. Wang L, Chen YW, Ho CY, Hsueh Liu YW, Chou FI, Liu YH, Liu HM, Peir JJ, Jiang SH, Chang CW, Liu CS, Lin KH,Wang SJ, Chu PY, Lo WL, Kao SY, Yen SH. Fractionated Boron Neutron Capture Therapy in Locally Recurrent Head and Neck Cancer: A Prospective Phase I/II Trial. Int J Radiation Oncol Biol Phys. 2016 . 95(1):396-403. 
  29. Huang HC, Kao SY, Chen SY, Yang CC. Osteosarcoma of mandible – A case report. Taiwan J Oral Maxillofac Surg. 2016.27(1): 38-45. 
  30. Kao SY, Tsai MM, Wu CH, Chen JJ, Tseng SH, Lin SC, Chan KW. Co-targeting of multiple microRNAs on factor-inhibiting hypoxia-inducible factor gene for the pathogenesis of head and neck carcinomas. HEAD NECK-J SCI SPEC 2016 APR ;38(4) :522-528. 
  31. Lin SC, Kao SY, Chang JCY, Liu YC, Yu EH, Tseng SH, Liu CJ, Chang KW. Up-regulation of miR-187 modulates the advances of oral carcinoma by targeting BARX2 tumor suppressor. Oncotarget 2016 SEP 20 ;7(38) :61355-61365. 
  32. Chen YF, Yang CC, Kao SY, Liu CJ, Lin SC, Chang KW. MicroRNA-211 Enhances the Oncogenicity of Carcinogen-Induced Oral Carcinoma by Repressing TCF12 and Increasing Antioxidant Activity. CANCER RESEARCH 2016 AUG 15 ;76(16) :4872-4886  
  33. Yeh CF, Li WY, Chu PY, Kao SY, Chen YW, Lee TL, Hsu YB, Yang CC, Tai SK. Pretreatment pain predicts perineural invasion in oral squamous cell carcinoma: A prospective study. ORAL ONCOLOGY 2016 OCT ;61 :115-119. 
  34. Lu WC, Liu CJ, Tu HF, Chung YT, Yang CC, Kao SY, Chang KW, Lin SC. miR-31 targets ARID1A and enhances the oncogenicity and stemness of head and neck squamous cell carcinoma. Oncotarget 2016 AUG 30 ;7(35) :57254-57267.    
  35. Yang CC , Tu HF, Wu CH, Chang HC, Chiang WF, Shih NC, Lee YS, Kao SY, Chang KW. Up-regulation of HB-EGF by the COX-2/PGE2 signaling associates with the cisplatin resistance and tumor recurrence of advanced HNSCC. ORAL ONCOLOGY 2016 MAY ;56 :54-61.   
  36. 黃弘昌; 高壽延; 陳盛鈺; 楊政杰.下顎骨骨肉瘤-病例報告 臺灣口腔顎面外科學會雜誌 2016 ;V.27(N.1) :P.38-45
  37. 楊令瑀; 黃加璋; 楊盈盈; 莊喬琳; 李文興; 張景智; 黃金洲; 黃惠君; 李發耀; 高壽延. ”Keyword-First Letter Mnemonics” Augments New Clinical Teacher’s Proficiency for Continuously Promotion of ”Professionalism/ System-Based Practice” Competencies 醫學教育 2016 ;V.20(N.2) :P.105-115
  38. 賴庭歡; 雷文天; 高壽延. 藥物相關之顎骨壞死的治療考量 臨床醫學 2016 ;V.78(N.2) :P.100-106
  39. 成函潔; 雷文天; 高壽延; 楊政杰.上顎牙骨質骨化纖維瘤－病例報告及文獻回顧. 臺灣口腔顎面外科學會雜誌 2016 ;V.27(N.4) :P.311-317  
  40. Kao SY, Tsai MM, Wu CH, Chen JJ, Tseng SH, Lin SC, Chan KW. Co-targeting of multiple microRNAs on factor-inhibiting hypoxia- inducible factor (FIH) gene for the pathogenesis of head and neck carcinomas. Head Neck; 2016 Apr;38(4):522-8.  
  41. Kao SY, Lui MT, Cheng DH, Chen TW. Lateral trap-door window approach with maxillary sinus membrane lifting for dental implant placement in atrophied edentulous alveolar ridge. J Chin Med Assoc 2015; 78: 85-88.  
  42. Kao SY, LIM Elva. An Overview of Detection and Screening of Oral Cancer in Taiwan. The Chinese Journal of Dental Research. 2015; 7-14. 
  43. Kao SY, Mao l, Jian XC, Gunaseelan Rajan, Yu KY. Expert consensus on the detection and screening or oral cancer and precancer. The Chinese Journal of Dental Research. 2015; 18:79-84. 
  44. Kao YY, Tu HF, Kao SY, Chang KW, Lin SC. The increase of oncogenic miRNA expression in tongue carcinogenesis of a mouse model. Oral Oncol. 2015 Dec;51(12):1103-12. 
  45. Yang HY, Lu KC, Fang WH, Lee HS, Wu CC, Huang YH, Lin YF, Kao SY, Lai CH, Chu CM, Su SL. Impact of interaction of cigarette smoking with angiotensin-converting enzyme polymorphisms on end-stage renal disease risk in a Han Chinese population . J THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEMMAR ;16(1) :203-210, 2015. 
  46. Hsiao PJ, Lin KS, Chiu CC, Chen HW, Huang JS, Kao SY, Lin YF, Chen JS .Use of traditional Chinese medicine (Ren Shen Yang Rang Tang) against microinflammation in hemodialysis patients: An open-label trial .COMPLEMENTARY THERAPIES IN MEDICINE JUN ;23(3) :363-371, 2015. 
  47. Kao SY, Shyu JF, Wang HS, Lin CH, Su CH, Chen TH, Weng ZC, Tsai PJ. Comparisons of Differentiation Potential in Human Mesenchymal Stem Cells from Wharton's Jelly, Bone Marrow, and Pancreatic Tissue. STEM CELLS INT Article Number:306158; 2015.  
  48. Hsing SC, Lu KC, Sun CA, Chien WC, Chung CH, Kao SY .The Association of Losartan and Ramipril Therapy With Kidney and Cardiovascular Outcomes in Patients With Chronic Kidney Disease A Chinese Nation-Wide Cohort Study in Taiwan . MEDICINE Article Number:e1999; 2015 DEC ;94(48). 
  49. Yu EH, Lui MT, Tu HF, Wu CH, Lo WL, Yang CC, Chang KW, Kao SY. Oral carcinoma with perineural invasion has higher nerve growth factor expression and worse prognosis. Oral Diseases: 20, 268–274. 2014.  
  50. Chen YW, Chen IL, Lin IC, Kao SY. Prognostic value of hypercalcaemia and leucocytosis in resected oral squamous cell carcinoma. Brit J Oral Max Surg: MAY ;52(5) :425-431, 2014. 
  51. Hung PS, Tu HF, Kao SY, Yang CC, Liu CJ, Huang TY, Chang KW, Lin SC. miR-31 is upregulated in oral premalignant epithelium and contributes to the immortalization of normal oral keratinocytes. Carcinogenesis: 2014 May;35(5):1162-71. 
  52. Liu CJ, Shen WG, Peng SY, Cheng HW, Kao SY, Lin SC, Chang KW. miR-134 induces oncogenicity and metastasis in head and neck carcinoma through targeting WWOX gene. Int J Cancer: FEB ;134(4) :811-821.2014. 
  53. Lin SP, Chiu FY, Wang Y, Yen ML, Kao SY, Hung SC. RB Maintains Quiescence and Prevents Premature Senescence through Upregulation of DNMT1 in Mesenchymal Stromal Cells. Stem Cell Reports: 2014 Dec 9;3(6):975-86. 
  54. Lu WC, Kao SY, Yang CC, Tu HF, Wu CH, Chang KW, Lin SC. EGF up-regulates miR-31 through the C/EBPβ signal cascade in oral carcinoma. PLoS One. 2014 Sep 17;9(9):e108049. 
  55. Hung PS, Liu CJ, Chou CS, Kao SY, Yang CC, Chang KW, Chiu TH, Lin SC. miR-146a Enhances the Oncogenicity of Oral Carcinoma by Concomitant Targeting of the IRAK1, TRAF6 and NUMB Genes. PLOS ONE: 8(11), 1-17. 2013.  
  56. Chang KW, Kao SY, Wu YH, Tsai MM, Tu HF, Liu CJ, Lui MT, Lin SC. Passenger strand miRNA miR-31* regulates the phenotypes of oral cancer cells by targeting RhoA. Oral oncology: 49(1) ,27-33.2013 
  57. Chen YS, Huang WL, Chang SH, Chang KW, Kao SY, Lo JF, Su PF. Enhanced filopodium formation and stem-like phenotypes in a novel metastatic head and neck cancer cell model. Oncol Rep. Dec;30(6):2829-37, 2013. 
  58. Chen YW, Kao SY, Wang HJ, Yang MH. Histone modification patterns correlate with patient outcome in oral squamous cell carcinoma. Cancer. Dec 15;119(24):4259-67, 2013. 
  59. Chen YW, Kao SY, Yang MH. Analysis of p16INK4A. Expression of Oral Squamous Cell Carcinomas in Taiwan:Prognostic Correlation Without Relevance to Betel Quid Consumption. Journal of Surgical Oncology: 106, 149–154, 2012. 
  60. Lo WL, Chu PY, Lee TH, Su TL, Chien Y, Chen YW, Huang PI, Tseng LM , Tu PH , Kao SY and Lo JF. A Combined DNA-Affinic Molecule and N-Mustard Alkylating Agent Has an Anti-Cancer Effect and Induces Autophagy in Oral Cancer Cells. Int. J. Mol. Sci. 13(3), 3277-3290, 2012 
  61. Chen YW, Chen CY, Chiang SC, Lui MT, Kao SY, Yang MH. Predictors and impact of microsurgical complications in patients with locally advanced oral squamous cell carcinoma. Cancer Science: 103(9) :1672-1678.2012. 
  62. Hung PS, Chang KW, Kao SY, Chu TH, Liu CJ, Lin SC. Association between the rs2910164 polymorphism in pre-mir-146a and oral carcinoma progression. Oral Oncology: 48(5) :404-408.2012. 
  63. Yang WH, Lan HY, Huang CH, Tai SK, Tzeng CH, Kao SY, Wu KJ,  Hung MC, Yang MH. RAC1 activation mediates Twist1-induced cancer cell migration. Nature Cell Biology: 14(4) :366-74.2012. 
  64. Tu HF, Liu CJ, Chang CL, Wang PW, Kao SY, Yang CC, Yu EH, Lin SC, Chang KW. The Association between Genetic Polymorphism and the Processing Efficiency of miR-149 Affects the Prognosis of Patients with Head and Neck Squamous Cell Carcinoma. PLoS One Article Number : 14 ;7(12).2012. 
  65. Tseng YH, Chang KW, Yang CC, Liu CJ, Kao SY, Liu TY, Lin SC*. Association between areca-induced vimentin expression and oral cancer progression. HEAD & NECK, 10.1002:245-253 2012. 
  66. Lo WL, Yu CC,  Chiou GY,  Chen YW,  Huang PI,  Chien CS,  Tseng LM,  Chu PY,  Lu KH,  Chang KW,  Kao SY,  Chiou SH. MicroRNA-200c attenuates tumour growth and metastasis of presumptive head and neck squamous cell carcinoma stem cells. J PATHOL. 223(4) :482-495.2011. 
  67. Lo WL,  Lai JY,  Feinberg SE,  Izumi K,  Kao SY,  Chang CS,  Lin A,  Chiang HK. Raman spectroscopy monitoring of the cellular activities of a tissue-engineered ex vivo produced oral mucosal equivalent. J RAMAN SPECTROSC: 42(2) :174-178.2011. 
  68. Kuo YL,  Tu TY,  Chang CF,  Li WY,  Chang SY,  Shiao AS,  Chu PY,  Chan KT,  Tai SK,  Wang YF,  Kao SC,  Kao SY,  Lo WL,  Wu CH,  Shu WH,  Ma S,  Wang TH. Extra-major salivary gland pleomorphic adenoma of the head and neck: a 10-year experience and review of the literature. EUR ARCH OTO-RHINO-L: 268(7) :1035-1040.2011. 
  69. Kao SY , Lo WL. Screening for oral cancers-Which method is most effective? J CHIN MED ASSOC: 74(12) :529-530.2011. 
  70. Lin IC, Anne MG, Chang,HJ, Kao SY, Chen DW. A 5-Year Follow-up of 80 Implants in 44 Patients Placed Immediately After the Lateral Trap-Door Window Procedure to Accomplish Maxillary Sinus Elevation Without Bone Grafting. The International Journal of Oral & Maxillofacial Implants :26,1079-86, 2011.    
  71. 楊盈盈、李發耀、徐會祺、高延壽、戴政宏、鄭浩民、李文興、莊喬琳、張景智、陳震寰.以迷你臨床演練評量評估牙醫系實習醫師之一般醫學臨床能力. 醫學教育 第十四卷 第㆕期 2010
  72. Fong Jenny HJ, Wu HT, Chio YW, Anne Margaret Gonzalez, Huang CK,Chen YW, Kao SY. Comprehensive Rehabilitation After Severe Maxillofacial Injury in a Cleft Patient. J Chin Med Assoc Vol 73 543-548 2010. 
  73. Lu,HH, Kao SY, Liu TY, Liu ST, Huang WP, Chang KW, Lin SC. Areca nut extract induced oxidative stress and upregulated hypoxia inducing factor leading to autophagy in oral cancer cells. Autophagy 6:6, 725-737 2010. 
  74. Su PF, Huang WL, Wu HT, Wu CH, Liu TY, and Kao SY. p16INK4A Promoter Hypermethylation is Associated with Invasiveness and Prognosis of Oral Squamous Cell Carcinoma in an Age-dependent Manner. Oral Oncology, 46: 734-739, 2010. 
  75. Fong Jenny HJ, Wu HT, Huang MC, Chou YW, Chi LY, Fong Y, Kao SY. Analiysis of facial skeletal characteristics in patient with chin deviation. J Chin Med Assoc, 73(1): 29-34 2010. 
  76. Chiu YW, Tu HF, Wang IK, Wu CH, Chang KW, Liu TY ,Kao SY.  The implication of osteopontin (OPN) expression and genetic polymorphisms of OPN promoter in oral carcinogenesis. Oral Oncology ,46: 302–306 2010 
  77. Chen YC, Chang CJ, Hsu HS, Chen YW, Tai LK, Tseng LM, Chiou GY, Chang SC, Kao SY, Chiou SH, Lo WL. Inhibition of Tumorigenicity and Enhancement of Radiochemosensitivity in Head and Neck Squamous Cancer-derived ALDH1-positive Cells by Knockdown of Bmi-1. Oral Oncol, 46:158-165 2010 
  78. Kao SY, Chen YP, Tu HF, Liu CJ, Yu AH, Wu CH, Chang KW. Nuclear STK15 expression is associated with aggressive behaviour of oral carcinoma cells in vivo and in vitro. J Pathol. 222:99-109, 2010. 
  79. Lu HH, Kao SY, Liu TY, Liu ST, Huang WP, Chang KW, Lin SC. Areca nut extract induced oxidative stress and upregulated hypoxia inducing factor leading to autophagy in oral cancer cells. Autophagy. 6(6):725-37 2010. 
  80. Wu CH, Wu ZY, Li CC, Lui MT, Chang KW, Kao SY. Impact of diabetes mellitus on the prognosis of patients with oral squamous cell carcinoma: a retrospective cohort study. Ann Surg Oncol; 17:2175-83 2010.  
  81. Liu CJ, Kao SY, Tu HF, Tsai MM, Chang KW*, Lin SC*. Increase of microRNA miR-31 level in plasma could be a potential marker of oral cancer Oral Diseases; 16, 360–364 2010. 
  82. Hung PS, Chen FC, Kao SY, Kuang SH, Lin SC*, Chang KW*. MicroRNA miR-146a expression induces the differentiation of periodontal ligament cells. JDR, 89(3): 252-257 2010. 
  83. Yang MH, Hsu SS Dennis, Wang HW, Wang HJ, Lan HY, Yang WH, Huang CH, Kao SY, Tzeng CH, Tai SK, Chang SY, Lee KS, Wu KJ. Bmi1 is essential in Twist1-induced epithelial–mesenchymal transition. Nature Cell Biology: 12 :982-992.2010.  
  84. Wu CH, Tu HF, Gong NR, Chen YW, Liu CJ, Kao SY. The Val allele of HER-2 codon 655 predicts the progression of oral squamous cell carcinoma. Oral Oncology, 45 579–583 2009. 
  85. 黃傳貴，吳政憲，羅文良，雷文天，高壽延: 糖尿病與癌症. 中華牙醫學會訊; 214:42-45 2009
  86. 邱昱瑋，劉宗榮，高壽延:骨調素(Osteopontin)在腫瘤中所扮演的角色.中華牙醫學會訊; 215:45-48 2009
  87. Lai YL, Kao SY, Yeung TC, Lee SY: Rapid implant therapies: immediate implant placement and immediate restoration. J Dent Sci; 4(1):1−6 2009. (SCI-E)
  88. Kao SY, Chu YW, Chen YW, Chang KW, Liu TY: Detection and Screening of Oral Cancer. J Chin Med Assoc.Vol 72 . No 5: 227-233 2009. 
  89. Wu CH, Tu HF, Gong NR, Chen YW, Liu CJ, Kao SY: The Val allele of HER-2 codon 655 predicts the progression of oral squamous cell carcinoma. Oral Oncology; 45:579–583 2009 
  90. Wu HT, Ko SY, Fong Jenny HJ, Liu TY, Kao SY: Expression of phosphorylated Akt in oral carcinogenesis and its induction by nicotine and alkaline stimulation. J Oral Pathol Med. 38: 206–213, 2009 
  91. Li CC,  Lui MT, Kao SY：Doctor-patient communication. J Dent Sci, 28(2):83-92 2008
  92. Cheng TF, Lui MT, Kao SY：Inform medical errors. J Dent Sci, 28(2):77-82 2008
  93. Huang CK, Lui MT, Kao SY：The sense of taste and teste disorder. J Dent Sci , 28(2):57-64 2008
  94. Chien CY, Lui MT, Kao SY、Wu CH：Risk factors assessment of osteoradionecrosis of jaw. J Dent Sci , 28(2):39-48 2008
  95. Tu HF, Chen HW, Kao SY, Lin SC, Liu CJ, Chang KW: MDM2 SNP 309 and p53 codon 72 polymorphisms are associated with the outcome of oral carcinoma patients receiving postoperative irradiation. RADIOTHER ONCOL. 87(2):243-52, 2008
  96. Lai KC, Chang KW, Liu CJ, Kao SY, Lee TC: IFN-induced protein with tetratricopeptide repeats 2 inhibits migration activity and increases survival of oral squamous cell carcinoma. MOL CANCER RES; 6(9):1431-9 2008
  97. Liaw YC, Kuang SH, Chen YW, Hung KF, Tsai HC, Kao SY, Fong HJ: Multimodality Treatment for Rehabilitation of Adult Orthodontic Patient with Complicated Dental Condition and Jaw Relation. J Chin Med Assoc; vol71.No11:594-600 2008. (SCI-E)
  98. Lu1 HH, Liu CJ, Liu TY, Kao SY, Lin SC and Chang KW: Areca-treated Fibroblasts Enhance Tumorigenesis of Oral Epithelial Cells. J Dent Res 87(11) :1069-1074 2008
  99. Chen Y.W., Yu E.H, Wu T.H., Lo W.L., Liand W.Y, Kao SY: Histopathological factors affecting nodal metastasis in tongue cancer: analysis of 94 patients in Taiwan. Int. J. Oral Maxillofac. Surg. 2008; 37: 912–916
  100. Cheng CY, Chang CS, Liu CJ and Kao SY : Vascular endothelial growth factor 936 C/T polymorphism is associated with vascular invasion in oral squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod;106:79-84, 2008
  101. Yu EH, Wu CH, Lo WL, Kao SY and Chang CS：Cervical Vertebrae Metastases in Oral Squamous Cell Carcinoma:A Case Report. Taiwan J Oral Maxillofac Surg 19:65-70, 2008
  102. F Yao, Chou SJ, Hung KF, Wu HT, Kao SY: An investigation of the differential expression of Her2/neu gene expression in normal oral mucosa, epithelial dysplasia, and oral squamous cell carcinoma in Taiwan. J Chin Med Assoc. 71:123–127, 2008. (SCI-E)
  103. Hung PS, Kao SY, Chiou YH, Liu CJ, Chang KW, Lin SC: Insulin-like growth factor binding protein-5 (IGFBP-5) suppersses the tumourigenesis of head and neck squamous cell carcinoma. J Pathol. 214:368-376, 2008
  104. Liaw YC, Kuang SH, Chen YW, Hung KF, Tsai HC, Kao SY, Jenny Fong HJ: Multimodalitytreatment for the rehabilitation of an adult orthodontic patient with complicated dental condition and jaw relation. J Chin Med Assoc • Vol 71 • No 11 594-600 2008. (SCI-E)
  105. Chen YW, Tu Hsi-Fen, Wu TH, Lo WL, Chang CS, Chang KW, Kao SY: Sarcomas and sarcomatoid tumor after radiotherapy of oral squamous cell carcinoma: Analysis of cases. Oral Surg, Oral Med, Oral Pathol, Oral Radiol, Endod. 105:65-71, 2008
  106. Chen TW, Chang HS, Leung KW, Kao SY: Implant placement immediately after the lateral approach of the trap door window procedure to create a maxillary sinus lift without bone grafting: a 2-year retrospective evaluation of 47 implants in 33 patients. J Oral Maxillofac Surg. 65:2324-2328, 2007 
  107. Chou SJ, Wu CH, Kao SY, Chang CS: Spindle Cell Carcinoma in the Oral Cavity. Asian J Oral Maxillofac Surg.19:170-5, 2007
  108. Wong IK, Wu HT, Fong HJ, Yu EH, Wu CH, Kao SY ,Lui MT, Pai SF.  A retrospective survival analysis of autotransplanted molars inTaipei Veterans General Hospital 1996~2004. J Dent Sci 2:193-200, 2007
  109. Chen YW, Lin JS, Wu CH, Lui MT, Kao SY, Fong Y: Application of in vivo stain of methylene blue as a diagnostic aid in the early detection and screening of oral squamous cell carcinoma and precancer lesions. J Chin Med Assoc. 70:497-503, 2007. (SCI-E)
  110. Chen YW, Lin JS, Fong HJ, Wang IK, Chou SJ, Wu CH, Lui MT, Chang CS, Kao SY. Use of methylene blue as a diagnostic aid in early detection of oral cancer and precancerous lesions. Br J Oral Maxillofac Surg. 45: 590-91, 2007 
  111. Tu HF, Wu CH, Kao SY, Liu CJ, Liu TY, Lui MT. Functional -1562 C-to-T polymorphism in matrix metalloproteinase-9 (MMP-9) promoter is associated with the risk for oral squamous cell carcinoma in younger male areca users. J Oral Pathol Med. Aug;36: 409-14, 2007
  112. Li YJ, Kao SY, and Chang CS: Leiomyosarcoma of cheek: a case report. Chin. J Oral Maxillofac Surg. 18:58-68, 2007.
  113. Chou S R, Wu CH, Kao SY, and Chang CS: Adult cervical cystic lymphangioma: a case report. Chin. J Oral Maxillofac Surg. 18: 39-46, 2007
  114. Chen TW, Huang TY, Chen YW, Chao SY, Chang CS, Kao SY: Implant rehabilitation of severely traumatized maxillary anterior alveolar ridge with mandibular ramus autogenous bone graft- cases analysis. Chin. J Oral Maxillofac Surg. 18: 9-19, 2007.
  115. Tseng YH, Chang CS, Liu TY, Kao SY, Chang KW, Lin SC: Areca nut extract treatment down-regulates involucrin in normal human oral keratinocyte through P13K/AKT activation. Oral Oncol. 43:670-679, 2007
  116. Kao SY, Fong HJ, Chou SJ, Wu JH, Tu HF, Yeung TC: Segmental osteotomy to reposition multiple osseointegrated dental implants in the anterior maxilla in a trauma patient. Dental Traumatlolgy 23: 56-59, 2007. 
  117. Chen IF, Lui MT, Kao SY: Allergy to local anesthetics in dental treatment. J Dent. Sci. 26: 49-60, 2006. 
  118. Wang IK, Yan AH, Lui MT, Wu CH, Kao SY: Dermatofibrosarcoma Protuberans of the face- case report and literature review. Chin. J Oral Maxillofac Surg. 17: 117-127, 2006.
  119. Hung KF, Chang CS, Liu CJ, Lui MT, Cheng CY, Kao SY: Differential expression of E-cadherin in metastatic lesions comparing to primary oral squamous cell carcinoma. J Oral Pathol Med. 35:589-94, 2006. 
  120. Yu EH, Lui MT, Chou SJ, Wang SJ, Hung KF, Lo WL, Chang CS, Wu CH, Kao SY: Comparison of Positron Emission Tomography and Computed Tomography for the Detection of Cervical Lymph Node Metastases of Oral Squamous Cell Carcinoma. Asian J Oral Maxillofacial Surg. 18: 109-115, 2006. (IM)
  121. Tu HF, Liu CJ, Chang CS, Lui MT, Kao SY, Chang CP, Liu TY: The functional (-1171 5A → 6A) polymorphisms of matrix metalloproteinase 3 gene as a risk factor for oral submucous fibrosis among male areca users. J Oral Pathol Med. 35: 99-103, 2006. 
  122. Jenny Fong HJ, Lui MT, Wu JH, Chou IC, Yeung TC, Kao SY: Using distraction osteogenesis for repositioning the dental implant retained premaxilla in conjunct with autogenous bone graft and mucosa graft vestibuloplasty in a trauma patient – report of a case. J Oral Maxillofac Surg. 64: 794-798, 2006. 
  123. Lin SC, Chang MF, Chung MY, Chang CS, Kao SY, Liu CJ, Chang KW: Frequent misrosatellite alterations of chromosome locus 4q13.1 in oral squamous cell carcinomas. J Oral Pathol Med. 34:209-13, 2005. SCI
  124. Chou SJ, Kao SY, Chang CS: Spindle cell carcinoma- case report. J Dent. Sci. 25: 165-170, 2005.
  125. Kao SY, Wu JH, Chang CS, and Chao SY: The Synopsis of Staging, Diagnosis and Treatment Modality of Oral Cancer. J Dent. Sci. 25:159-164, 2005
  126. Kao SY, Fong HJ, Lui MT, Yeung TC, Hung KF, Wu CH, Yu EH, Wu HT, Chang CS: Implant rehabilitation of severely traumatized anterior alveolar ridge. Asian J Oral Maxillofacial Surg. 17 (4): 240-246, 2005. (IM)
  127. Wu CW, Hung KF, Yeung TC, Kao SY: A method using vestibulo-sulcoplasty simultaneously combining spilt-thickness skin graft and palatal keratinized mucosa graft for rehabilitation of peri-implant tissue in the severely atrophic edentulous ridge secondary to oral cancer surgery. J Oral Implantol 31 (4): 186-191, 2005. (IM)
  128. Joe Chou IC, Fong HJ, Kuang SH, Gi LY, Hwang FY, Lai YC, Richard Chang CS, Kao SY: A retrospective analysis of the stability and relapse of soft and hard tissue change after bilateral sagittal split osteotomy for mandibular setback of 64 Taiwanese patients. J Oral Maxillofac Surg. 63:355-361, 2005. 
  129. 于恩浩, 吳政憲, 羅文良, 高壽延, 張哲壽: 前哨淋巴結切片在治療頭頸部癌症所扮演的角色. 中華牙醫學會訊: 32-34, 2005一、二月號.
  130. Wu CH, Tu HF, Fong HJ, Chang, CS, Kao SY: Antisense oligonucleotide therapy for oral squamous cell carcinoma in a nude mouse model. Asian J Oral Maxillofac Surg. 16: 109-115, 2004. (IM)
  131. Yu EH, Kao SY, Richard Chang CS: Tumor angiogenesis in cancer therapy. J Dent Sci. 24:65-70, 2004.
  132. Wu CS, Li YZ, Tu SF, Lo WL, Kao SY, Chang CS: Using microscopic MRI for observation of bone regeneration in animal model. J Dent. Sci. 24:21-29, 2004.
  133. Wu CS, Chen YW, Lo WL, Lui MT, Chang CS, Kao SY: The 2002~2003 year cancer bulletin of oral squamous cell carcinoma at oral and maxillofacial surgery in Taipei Veterans General Hospital. J Dent Sci. 24:15-20, 2004.
  134. Chou IC, Wu CH, Tu HF, Kao SY: Analysis of dental emergencies as Taipei Veterans General Hospital in 2003. Chin. J Oral Maxillofac Surg. 15:7-17, 2004.
  135. Tu HF, Yu IT, Chang KW, Chang CS, Kao SY: Peripheral T-cell lymphoma of the maxillary gingival. Asia J Oral Maxillofac Surg. 16:184-188, 2004.
  136. Kao SY, Tu HF, Chang KW, Chang CS, Yang AH, Li WY: Epitheloid sarcoma metastasis to the gingivae: a case report. Int. J Oral Maxillofac Surg. 33: 205-208, 2004. 
  137. 高壽延, 陳雅薇, 吳政憲, 羅文良, 雷文天, 張哲壽: 口腔癌篩檢的重要性. 中華牙醫學會訊: 19-22, 2004九、十月號.
  138. Wu CW, Yeung TC, Lui MT, Chang CS, Kao SY: Reconstruction of the severe atrophic ridge of the mandible after traffic accident with guided bone regeneration combined with palatal mucosa graft and vestibuloplasty for implant rehabilitation– a case report. Chin. J Oral Maxillofac Surg. 15: 99-107, September 2004.
  139. 李育融, 林雙蘊, 張程, 羅文良, 高壽延, 張哲壽: Using microscopic MRI for observation of bone regeneration in animal model (以顯微鏡核磁共振照影儀來觀察與量化動物實驗結果). 中華牙醫學會訊: 40-44, 2004七、八月號.
  140. 吳和泰, 高壽延, 張哲壽, 劉宗榮: 檳榔子化學成分之致癌性. 中華牙醫學會訊: 36-40, 2004三、四月號.
  141. Wu CH, Kao SY, Lo WL, YX Li, Chang CS: A case report of non-small cell lung cancer metastasizing to oral cavity. Chin. J Oral Maxillofac Surg. 15: 27-37, March 2004.
  142. 吳智偉, 楊子彰, 高壽延: 病例報告--一位車禍外傷患者經硬組織與軟組織重建後之植體贗復手術. 中華牙醫學會訊: 17-18, 2003十二月號.
  143. 林鈞盛, 季麟揚, 高壽延, 張哲壽: 口腔黏膜鱗狀細胞癌篩檢之試劑簡介. 中華牙醫學會訊: 12-16, 2003十二月號.
  144. 陳雅薇, 高壽延, 張哲壽: 放射線治療引發的繼發性癌症. 中華牙醫學會訊: 16-20, 2003五、六月號.
  145. Lo WL, Richard Chang CS, Yang AH, Kao SY: Aspergillosis of the temporomandibular joint following irradiation of the parotid region: a case report. Int. J Oral Maxillofac Surg. 32: 560-562, 2003. 
  146. Hung KF, Lin SC, Liu CJ, Chang CS, Chang KW, Kao SY: Outcomes of oral squamous differential expression of the cellular membrane protein, caveolin-1, in oral carcinogenesis. J Oral Pathol Med. 32: 461-467, 2003. 
  147. Lo WL, Kao SY, Chi LY, Wong YK, Chang RCS. Outcomes of oral squamous cell carcinoma in Taiwan after surgical therapy: factors affecting survival. J Oral Maxillofac Surg. 61: 751-758, 2003. 
  148. Tu HF, Yang J, Chang CS, Kao SY: Vestibuloplasty using palatal mucosa graft in compromised alveolar ridge due to tumor ablation surgery– a case report. Chin. J Oral Maxillofac Surg. 13: 40-50, 2002.
  149. Iou GT, Yang J, Lo WL, Huan TY, Chang CS, Kao SY: Using minocycline sclerosing therapy for the management of chyle leakage after radical neck dissection for a recurrent oral cancer patient. Chin J Oral Maxillofac Surg. 13: 10-18, 2002.
  150. Yang CC, Tu HF, Wu CH, Richard Chang CS, Kao SY: In vitro growth inhibition by indomethacin on human oral squamous cell carcinoma lines synergistically suppressed by all-trans retinoic acid correlating to apoptosis. Chin. Med J 65: 600-607, 2002. (IM)
  151. Kao SY, Yeung TC, Lo WL, Wu CH, Lui MT, Richard Chang CS: Rehabilitation of Dental Implants for the Post-irradiated and Marginally Resected Mandible in an Oral Cancer Patient. Chin. Med J 65: 548-552, 2002. (IM)
  152. Kao SY, Tu HF, Yang CC, Chang KW, Chang CS, and Lin SC: The retinoic acid receptor-β (RAR-β) mRNA expression in the oral squamous cell carcinoma associated with betel quid use. J Oral Pathol Med 31: 220-226, 2002. 
  153. Lin SC, Wang CP, Chen YM, Lu SY, Fann MJ, Liu CJ, Kao SY, Chang KW: Regulation of IGFBP-5 expression during tumourigenesis and differentiation of oral keratinocytes. J. Pathol 198: 317-325, 2002. 
  154. Kao SY, Yeung TC, Hung KF, Chou IC, Wu CH, Chang CS: Transposition flap vestibuloplasty combined with implant surgery in the severely resorbed atrphic edentulous ridge. J Oral Implantol 28 (4): 194-199, 2002.
  155. Kao SY, We CH, Lin SC, Yap SK, Chang CS, Wong YK, Chi LY, Liu TY: Genetic polymorphism of cytochrome P4501A1 and susceptibility to oral squamous cell carcinoma and oral precancer lesions associated with smoking/betel use. J Oral Pathol Med. 31: 505-511, 2002. 
  156. Chang KW, Kao SY, Tzeng RJ, Liu CJ, Cheng AJ, Yang SC, Wong YK and Lin SC: Multiple molecular alterations of FHIT in betel-associated oral carcinoma. J Pathol 196: 300-306, 2002. 
  157. Lin SC, Chen YJ, Kao SY, Hsu MT, Lin CH, Yang SC, Liu TY, Chan KW: Chromosomal changes in betel-associated oral squamous cell carcinomas and their relationship to clinical parameters. Oral Oncol 38:266-273, 2002. 
  158. Kao SY, Yeung TC, Chou IC, Chang CS: Reconstruction of the severely resorbed atrophic edentulous ridge of maxilla and mandible for implant rehabilitation: report of a case. J Oral Implantol 28: 128-132, 2002. 
  159. Kao SY, Tu HF, Chang RC, Yang AH, Chang KW, Lee CH: Primary ectopic thyroid carcinoma occurring in the floor of mouth and tongue: a case report. Br. J Oral Maxillofac Surg. 40:213-5, 2002. 
  160. Kao SY, Yang J, Yang AH, Chang KW, Chang RC: Peripheral primitive neuroectodermal tumor of maxillary gingivae with metastasis to cervical lymph nodes- reports of a case. J Oral Maxillofac Surg. 60:821-825, 2002. 
  161. Chou IC, Kao SY, Li WY, Hsu HS, Shih CW, Chang CS: Oral metastasis of renal cell carcinoma- a case report. Chin. J Oral Maxilofac Surg. 12:17-27, 2001.
  162. Yang CC, Kao SY, Chang CS: Carcinoma ex pleomorphic adenoma of deep lobe of parotid gland- a case report. Chin. J Oral Maxilofac Surg. 12: 45-54, 2001.
  163. Wu CS, Kao SY, Chang SC: An overview of the detection & screening of oral cancer and pre-cancer. J Dent Sci. 21:95-100, 2001.
  164. Huang TY, Kao SY, Chang CS: Cervical ranula- a case report and literature review. Chin. J Oral Maxillofac Surg. 12(1):55-62 March 2001.
  165. Tse YW, Lui MT, Kao SY, Li WS, Chang CS: Odontogenic keratocyst - multiple recurrence and 10 years long term follow up case report. Chin J Oral Maxillofac Surg. 12(1):36-44 March 2001.
  166. Lo WL, Kao SY, and Chang CS: Diagnosis and treatment of internal derangement of TMJ. J Dent. Sci. 47:354-360, 2001.
  167. Kao SY, His-Feng Tu, Jack Yang, and Wen-Liang Lo, Che-Shoa Chang: An Overview of the Detection and Screening of Oral Cancer and Pre-cancer. Chin J Oral Maxillofac Surg. 12: 91-99, 2001.
  168. Kao SY, Iou GT, Lo WL, Chang YL, Su CY, and Chang CS:  An overview of retrospective and prospective researches on ceramic bone substitute hydroxylapatite-HA. Chin. Dent. J 20:227-242, 2001.
  169. Lee HC, Yin HP, Yu TN, Chang YD, Hsu WC, Kao SY, Chi CW, Liu TY, Wei YH: Accumulation of mitochondrial DNA deletions in human oral tissues- effects of betel quid chewing and oral cancer. Mutation Res. 493: 67-74, 2001. .
  170. Yang CC, Tu SF, Chang CS, Kao SY: In vitro cellular response of retinoic acid treated human oral cancer cell lines. Chin. Med. J. 64:357-363, 2001.
  171. Kao SY, Yang J, Chang KW, Li WY, Chang CS: Maxillary amelanotic melanoma: a case report. J Oral Maxillofac Surg. 59: 700-703, 2001. 
  172. Tu HF, Chang CS, Chang KW, Kao SY: Chemoprevention of Vit-A in oral cancer. J Clin. Med. 48:23-28, 2001.
  173. Hwang MJ, Kuang SS, Kao SY, Fong HJ: The etiology assessment, diagnosis and Tx of facial asymmetry. J Clin. Med. 48:34-41, 2001.
  174. Tse YW, Kao SY, Wang YW, Chang CS: Treatment of commonly seen oral lesion in AIDS. J Clin. Med. 48:29-33, 2001.
  175. Kao SY, Lo J, Chou J, Yang J, Chou AP, Wong JH, Chang CS: Hyperbaric oxygen therapy of maxillary osteomyelittis with infection to ethmoid sinus, orbit and base of skull. Asian J Oral Maxillofac Surg. 13(1):55-60, 2001.
  176. Wu CS, Huang TI, Kao SY: The role of telomere & telomerase in human cancer: Part I. J Dent. Sci. 20:167-172, 2000.
  177. Tse YW, Kao SY, Lui MT, Chang KW, Chang CS: Oral Manifestation of AIDS. J Dent Sci. 20: 111-114, 2000.
  178. Yang CC, Kao SY, Chang CS: The effect of NSAIDs in tumor suppression. J Dent. Sci. 20: 115-120, 2000.
  179. Tse YW, Lui MT, Kao SY, Chang CS: The dental care of diabetes mellitus patients. J Dent Sci. 20: 121-126, 2000.
  180. Huang TY, Kao SY, Chang CS: Introduction of distraction osteogenesis. J Dent. Sci. 20: 49-52, 2000.
  181. Huang TY, Kao SY, Chang CS: Early detection of oral squamous cell carcinoma by toluidine blue. J Dent. Sci. 20: 11-16, 2000.
  182. Chou IC, Kao SY, Chang CS: Diabetes mellitus and wound healing. J Dent. Sci. 20:41-48, 2000.
  183. Kao SY, Tu SF, Yang J, Chang CS: Biologic functions and tumor suppressor effect of retinoids. Chin. Dent J 19(3):155-66, 2000.
  184. Chang CS Kao SY: Biomechanical and histological studies of particulate hydroxylapatite implanted in femur bone defects of adult dogs: Int. J Oral Maxillofac Surg. 29: 54-61, 2000. 
  185. Kao SY, Yang CC, Chang CS: Knowing the oral cancer. Chin. J. Oral Maxillofac Surg. 41-43, 1999.
  186. Kao SY, Chou IC, Lui MT, Chang CS: Prepresthetic surgery in the atrophic ridged of aged patients. Newsletter Assoc Dent Sci ROC. 18-22, 1999.
  187. Yang CC, Kao SY, Chang CS: The potential role of retinoid in oral carcinogenesis. J Dent Sci, 19: 223-30, 1999.
  188. Chou AP, Kao SY, Chang CS: Malignant melanoma of oral mucosa – report of a case. Chin J Oral Maxillofac Surg, 10:101-8, 1999.
  189. Kao SY, Luo J, Yang J, Jo CJ, Chang RC: Coronal approach for the replacement of condylar head in bilateral temporomandibular joint ankylosis: report of 3 Cases. Chin Med J (Taipei), 62:388-394, 1999.
  190. Kao SY, Chou J, Luo J, Yang J, Chou AP, Joe CJ, Chang CS: Using 3D-CT as a Diagnostic Tool for Temporo-mandibular Joint Ankylosis: a case report. Chin Med J (Taipei), 62(4): 244-249, 1999.
  191. Kao SY, Luo WL, Jo CJ, Chang CS: Using bicoronal scalp flap to approach TMJs in ankylosing spondylitis patients. Newsletter Assoc Dent Sci ROC. 138: 18-19, Mar. 1999.
  192. Lo WL, Kao SY, Chang CS: Surgical treatment of the temporomandibular disorders. J Dent Sci. 19: 105 - 110, 1998.
  193. Chou IC, Kao SY, Chang CS: Implant in surgical compromised conditions. J Dent Sci. 18:193-196, 1998.
  194. Lo WL, Kao SY, Chang CS: Necrotizing fasciitis of neck due to odontogenic infection- report of a case. Chin J Oral Maxillofac Surg, 9: 24-32, 1998.
  195. Chou IC, Kao SY, Chang CS: The principles and tissue response of laser surgery. J Dent Sci 18:34-37, 1998.
  196. Kao SY, Chang YL, Wong YK, Chang CS: Post-operative complications associated with reconstruction of mandibular defects after cancer surgery. Asian J Oral Maxillofac Surg 10: 75-87, 1998.
  197. Kao SY, Ma S, Chang CS: The introduction of mandibular reconstruction after tumor resection. Newsletter Assoc Dent Sci ROC. 130: 14-18, Mar. 1998.
  198. Kao SY, Chang KW, Chang CS: Vitamine-A and oral squamous cell carcinoma. Newsletter Assoc Dent Sci ROC. 128: 10-11, Jan. 1998.
  199. Kao SY, Chou IC, Chang CS: The application of 3D-CT in maxillofacial reconstruction. Newsletter Assoc Dent Sci ROC. 126:22-24, Nov. 1997.
  200. Kao SY, Chou I C, Chang CS: The application of laser in the maxillofacial soft tissue surgery. Newsletter Assoc Dent Sci ROC. 124: 29-30, Sep., 1997.
  201. Kao SY, Lin YL, Chang CS: The HBO therapy in post irradiated ORN. Newsletter Assoc Dent Sci ROC. 122: 21-24, July, 1997.
  202. Yang CC, Kao SY, Chang CS: Oncogenes and tumor suppressor genes. J Dent Sci. 17:241-248, 1997.
  203. Kao SY: Genetic basis of human oral cancer. J Dent Sci, 17:227-240, 1997.
  204. Kao SY, Wu FT: Biologic functions of retinoids (Vitamin-A derivatives) - (I). J Dent Sci, 17: 119 - 127, 1997.
  205. Yang CC, Kao SY, Chang CS: Malignant transformation of oral cancer. J Dent Sci. 17: 105 - 110, 1997.
  206. Lin KC, Joe CJ, Kao SY, Chang CS: Combined trapezius myocutaneous flap with pectoralis major myocutaneous flap in reconstruction of head and neck tumor surgery. Chin J Oral Maxillofac Surg 8:63-70, 1997.
  207. Joe CJ, Kao SY, Chang CS: Application of coronal approach in replacement of bilateral TMJ with artificial joint: a case report. Chin J Oral Maxillofac Surg, 7: 108-119, 1996.
  208. Kao SY, Pong BY, Li WY, Gallagher GT, Chang RC: Maxillary odontogenic carcinoma with distant metastasis to axillary skin, brain, and lung: case report. Int J Oral Maxillofac Surg, 24: 229-232, 1995. 
  209. Chang CS, Kao SY, Peng BY: Histological study of hydroxylapatite with tricalcium phosphate as an implant for repairing bony defect. Chin J Oral Maxillofac Surg, 5:29-34, 1994.
  210. Peng BY, Kao SY, Chang YL, Chang CS: Microsurgery – free flap reconstruction in oral and maxillofacial surgery. J Dent Sci, 13: 208-215, 1993.
  211. Peng BY, Kao SY, Chang CS: The anatomy and clinical significance of buccal fat pad. Chin J Oral Maxillofac Surg, 1993.
  212. Kao SY, Chang CS, Wong YK, Chang YL, Lee L: Reconstruction of mandible with HA/Collagen and titanium mesh in Macaca Cyclopis. Chin J Oral Maxillofac Surg, 1992.
  213. Kao SY, Chang CS, Wong YK, Chang YL, Lee G: Reconstruction of mandible with HA/Collagen and titanium mesh in macaca cyclopis. Chin J Oral Maxillofac Surg. 2:15-27, 1991.
  214. Chang RC, Chung KH, Kao SY: Histological and biomechanical studies of hydroxylapatite implant. Proc. NSC, ROC, Part B: Life Sci. 15:212-219, 1991.
  215. Chang CS, Kao SY, Chang YL, Wong YK: The effect of hydroxylapatite upon stimulating new bone formation in host tissue. Chin. J. Oral Maxillo-fac. Surg. 1(2):1-12, 1990.
  216. Chang CS, Wong YK, Leung KW, Chang YL, Kao SY: Reconstruction of mandible with hydroxylapatite and particulate bone marrow contained in a titanium tray: case report. Chin Med J (Taipei), 46:385-390, 1990.
  217. Kao SY, Chang CS, Wong YK, Chang YL: A histological study by using HA/BMP mixture as an implant in cranial defect of adult dogs. Chin Med J (Taipei), 46:369-376, 1990.
  218. Kao SY, Wong YK, Chang CS, Wu FD, Pong CJ, Hsi BL: Surgico-orthodontics case report. J. Dent. Sci., 10:133-138, 1990.
  219. Chang CS, Tay HH, Kao SY: Evaluation of augmentation of the atrophic alveolar ridge in the mandible by subperiosteal implantation with hydroxylapatite. Hosp Dent (Tokyo), 2:25-29, 1990.
  220. Kao SY, Wong YK: Comparison of conventional sialography and computed tomography in diagnosis of salivary gland disease. J. Dent. Sci. 10: 121-126, 1990.
  221. Kao SY, Wong YK, Chang CS: Complication of odontogenic infection-orbital cellulitis. J. Dent. Sci., 10:25-29, 1990.
  222. Kao SY, Leung YK, Wong  YK, Chang CS: Mandible reconstruction J Dent. Sci., 10:19-24, 1990.
  223. Kao SY, Lieu YL, Chang YL, Choi MP, Chang CS: Histological study of hydroxylapatite mixed with collagen as osseous implant in mandible. Chin. Med. J. (Taipei), 44:229-234,1989.
  224.  Kao SY, Chang CS: Alveolar ridge augmentation with particulate hydroxylapatite. Clin. Dent., 7: 227 - 232, 1987.

最後更新：